SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950162-10-000197
Filing Date
2010-06-28
Accepted
2010-06-28 16:19:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SIGMA TAU PHARMACEUTICALS-SOLIGENIX 13D/A NO.2 sigmapharmsol13dano2_061810.htm SC 13D/A 263928
  Complete submission text file 0000950162-10-000197.txt   266169
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-39976 | Film No.: 10920246
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877
Business Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877 1-800-447-0169
Sigma-Tau Pharmaceuticals, Inc. (Filed by) CIK: 0001385625 (see all company filings)

IRS No.: 953566292 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D/A